Prostate Cancer Reports


Volume 2 Supplement 7
 July 2014
Home > Prostate Cancer Reports > Volume 2 - Year 2014 > Supplement 7, July 2014

CONTENTS



Diagnosis and evaluation
Integrative medicine
Overall management
Prognosis and outcome
Staging





Hattori S, Kosaka T, Mizuno R, Kanao K, Miyajima A, Yasumizu Y, Yazawa S, Nagata H, Kikuchi E, Mikami S, Jinzaki M, Nakagawa K, Tanimoto A, Oya M.
Prognostic value of preoperative multiparametric magnetic resonance imaging (MRI) for predicting biochemical recurrence after radical prostatectomy.
BJU Int. 2014 May;113(5):741-7. doi: 10.1111/bju.12329. Epub 2013 Aug 13.
Abstract | Full text | Related citations



Chesnokov V, Sun C, Itakura K.
Glucosamine suppresses proliferation of human prostate carcinoma DU145 cells through inhibition of STAT3 signaling.
Cancer Cell Int. 2009 Sep 10;9:25. doi: 10.1186/1475-2867-9-25.
Abstract | Full text | Related citations



Meetings

Epstein JI, Allsbrook WC Jr, Amin MB, Egevad LL; ISUP Grading Committee.
The 2005 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma.
Am J Surg Pathol. 2005 Sep;29(9):1228-42.
Abstract | Full text | Related citations



Nomograms

Crippa A, Srougi M, Dall'Oglio MF, Antunes AA, Leite KR, Nesrallah LJ, Ortiz V.
A new nomogram to predict pathologic outcome following radical prostatectomy.
Int Braz J Urol. 2006 Mar-Apr;32(2):155-64.
Abstract | Full text | Related citations


A) Nomograms to predict PSA recurrence/disease free/general survival after RP

Preoperative

Acimovic M, Dabic-Stankovic K, Pejcic T, Dzamic Z, Rafailovic D, Hadzi-Djokic J.
Preoperative Gleason score, percent of positive prostate biopsies and PSA in predicting biochemical recurrence after radical prostatectomy.
J BUON. 2013 Oct-Dec;18(4):954-60.
Abstract | Full text | Related citations


Cooperberg MR, Pasta DJ, Elkin EP, Litwin MS, Latini DM, Du Chane J, Carroll PR.
The University of California, San Francisco Cancer of the Prostate Risk Assessment score: a straightforward and reliable preoperative predictor of disease recurrence after radical prostatectomy.
J Urol. 2005 Jun;173(6):1938-42. Erratum in: J Urol. 2006 Jun;175(6):2369.
Abstract | Full text | Related citations


D'Amico AV, Whittington R, Malkowicz SB, Fondurulia J, Chen MH, Kaplan I, Beard CJ, Tomaszewski JE, Renshaw AA, Wein A, Coleman CN.
Pretreatment nomogram for prostate-specific antigen recurrence after radical prostatectomy or external-beam radiation therapy for clinically localized prostate cancer.
J Clin Oncol. 1999 Jan;17(1):168-72.
Abstract | Full text | Related citations


D'Amico AV, Whittington R, Malkowicz SB, Fondurulia J, Chen MH, Tomaszewski JE, Wein A.
The combination of preoperative prostate specific antigen and postoperative pathological findings to predict prostate specific antigen outcome in clinically localized prostate cancer.
J Urol. 1998 Dec;160(6 Pt 1):2096-101.
Abstract | Related citations


Kattan MW, Eastham JA, Stapleton AM, Wheeler TM, Scardino PT.
A preoperative nomogram for disease recurrence following radical prostatectomy for prostate cancer.
J Natl Cancer Inst. 1998 May 20;90(10):766-71.
Abstract | Full text | Related citations


Shariat SF, Walz J, Roehrborn CG, Zlotta AR, Perrotte P, Suardi N, Saad F, Karakiewicz PI.
External validation of a biomarker-based preoperative nomogram predicts biochemical recurrence after radical prostatectomy.
J Clin Oncol. 2008 Mar 20;26(9):1526-31. doi: 10.1200/JCO.2007.12.4669.
Abstract | Full text | Related citations


Stephenson AJ, Scardino PT, Eastham JA, Bianco FJ Jr, Dotan ZA, Fearn PA, Kattan MW.
Preoperative nomogram predicting the 10-year probability of prostate cancer recurrence after radical prostatectomy.
J Natl Cancer Inst. 2006 May 17;98(10):715-7. Erratum in: J Natl Cancer Inst. 2012 Mar 7;104(5):423.
Abstract | Full text | Erratum | Related citations


Nomogram for predicting Gleason score upgrading

Chun FK, Steuber T, Erbersdobler A, Currlin E, Walz J, Schlomm T, Haese A, Heinzer H, McCormack M, Huland H, Graefen M, Karakiewicz PI.
Development and internal validation of a nomogram predicting the probability of prostate cancer Gleason sum upgrading between biopsy and radical prostatectomy pathology.
Eur Urol. 2006 May;49(5):820-6. Epub 2005 Dec 22.
Abstract | Full text | Related citations


Postoperative

Graefen M, Noldus J, Pichlmeier U, Haese A, Hammerer P, Fernandez S, Conrad S, Henke R, Huland E, Huland H.
Early prostate-specific antigen relapse after radical retropubic prostatectomy: prediction on the basis of preoperative and postoperative tumor characteristics.
Eur Urol. 1999;36(1):21-30.
Abstract | Related citations


Kattan MW, Wheeler TM, Scardino PT.
Postoperative nomogram for disease recurrence after radical prostatectomy for prostate cancer.
J Clin Oncol. 1999 May;17(5):1499-507.
Abstract | Full text | Related citations


McAleer SJ, Schultz D, Whittington R, Malkowicz SB, Renshaw A, Wein A, Richie JP, D'Amico AV.
PSA outcome following radical prostatectomy for patients with localized prostate cancer stratified by prostatectomy findings and the preoperative PSA level.
Urol Oncol. 2005 Sep-Oct;23(5):311-7.
Abstract | Related citations


Stephenson AJ, Scardino PT, Eastham JA, Bianco FJ Jr, Dotan ZA, DiBlasio CJ, Reuther A, Klein EA, Kattan MW.
Postoperative nomogram predicting the 10-year probability of prostate cancer recurrence after radical prostatectomy.
J Clin Oncol. 2005 Oct 1;23(28):7005-12.
Abstract | Full text | Related citations


Stephenson AJ, Wood DP, Kattan MW, Klein EA, Scardino PT, Eastham JA, Carver BS.
Location, extent and number of positive surgical margins do not improve accuracy of predicting prostate cancer recurrence after radical prostatectomy.
J Urol. 2009 Oct;182(4):1357-63. doi: 10.1016/j.juro.2009.06.046. Epub 2009 Aug 14.
Abstract | Related citations


Postoperative - Early recurrence (< 2 years)

Walz J, Chun FK, Klein EA, Reuther A, Saad F, Graefen M, Huland H, Karakiewicz PI.
Nomogram predicting the probability of early recurrence after radical prostatectomy for prostate cancer.
J Urol. 2009 Feb;181(2):601-7; discussion 607-8. doi: 10.1016/j.juro.2008.10.033. Epub 2008 Dec 13.
Abstract | Related citations


Postoperative - Aggressive recurrence (< 9 months)

Schroeck FR, Kattan MW, Moul JW, Aronson WJ, Presti JC Jr, Terris MK, Kane CJ, Amling CL, Sun L, Freedland SJ.
Re-calibration and external validation of an existing nomogram to predict aggressive recurrences after radical prostatectomy.
BJU Int. 2010 Jun;105(12):1654-9. doi: 10.1111/j.1464-410X.2009.09060.x. Epub 2009 Nov 13.
Abstract | Related citations


B) Nomograms to predict Prostate Cancer Specific Mortality After RP

Eggener SE, Scardino PT, Walsh PC, Han M, Partin AW, Trock BJ, Feng Z, Wood DP, Eastham JA, Yossepowitch O, Rabah DM, Kattan MW, Yu C, Klein EA, Stephenson AJ.
Predicting 15-year prostate cancer specific mortality after radical prostatectomy.
J Urol. 2011 Mar;185(3):869-75. doi: 10.1016/j.juro.2010.10.057. Epub 2011 Jan 15.
Abstract | Full text | Related citations


Porter CR, Suardi N, Capitanio U, Hutterer GC, Kodama K, Gibbons RP, Correa R Jr, Perrotte P, Montorsi F, Karakiewicz PI.
A nomogram predicting prostate cancer-specific mortality after radical prostatectomy.
Urol Int. 2010;84(2):132-40. doi: 10.1159/000277588. Epub 2010 Mar 4.
Abstract | Full text | Related citations


Stephenson AJ, Kattan MW, Eastham JA, Bianco FJ Jr, Yossepowitch O, Vickers AJ, Klein EA, Wood DP, Scardino PT.
Prostate cancer-specific mortality after radical prostatectomy for patients treated in the prostate-specific antigen era.
J Clin Oncol. 2009 Sep 10;27(26):4300-5. doi: 10.1200/JCO.2008.18.2501. Epub 2009 Jul 27.
Abstract | Full text | Related citations


Prognostic factors

Percentage of positive fragments in biopsies

Antunes AA, Dall'Oglio MF, Sant'Anna AC, Paranhos M, Leite KR, Srougi M.
Prognostic value of the percentage of positive fragments in biopsies from patients with localized prostate cancer.
Int Braz J Urol. 2005 Jan-Feb;31(1):34-41.
Abstract | Full text | Related citations


Dall'Oglio MF, Crippa A, Oliveira LC, Neves Neto JF, Leite KR, Srougi M.
Prediction of pathological stage in prostate cancer through the percentage of involved fragments upon biopsy.
Int Braz J Urol. 2005 Sep-Oct;31(5):445-51.
Abstract | Full text | Related citations


Freedland SJ, Csathy GS, Dorey F, Aronson WJ.
Percent prostate needle biopsy tissue with cancer is more predictive of biochemical failure or adverse pathology after radical prostatectomy than prostate specific antigen or Gleason score.
J Urol. 2002 Feb;167(2 Pt 1):516-20.
Abstract | Related citations


Noronha MR, Quintal MM, Magna LA, Reis LO, Billis A, Meirelles LR.
Controversial predictors of biochemical recurrence after radical prostatectomy: a study from a Latin American (Brazilian) institution.
Int Braz J Urol. 2013 Nov-Dec;39(6):779-92. doi: 10.1590/S1677-5538.IBJU.2013.06.03.
Abstract | Full text | Related citations



Gleason score

Capitanio U, Karakiewicz PI, Jeldres C, Briganti A, Gallina A, Suardi N, Cestari A, Guazzoni G, Salonia A, Montorsi F.
The probability of Gleason score upgrading between biopsy and radical prostatectomy can be accurately predicted.
Int J Urol. 2009 May;16(5):526-9. doi: 10.1111/j.1442-2042.2009.02270.x. Epub 2009 Mar 26.
Abstract | Full text | Related citations